If these patients eat less sugar and fat, it can change the whole market
From 2022 through early 2025, compounded semaglutide grew explosively because brand semaglutide was on the FDA shortage list
If you have been running on low growth hormone for years, the sudden increase creates a more dramatic shift
Lifestyle Still Matters on GLP-1 A mistake some women make is expecting medication to do everything
In one systematic review, roughly half to two-thirds of perimenopausal women reported hot flashes or night sweats, so overlap is the rule, not the exception
Despite these findings, to our knowledge, there are no large population-based studies that have investigated the incidence of new-onset major cardiovascular events or clinically significant portal hypertension events in patients with MASLD who are receiving treatment with GLP-1 agonists for any indication